Penumbra reveals positive data for algorithm-assisted thrombectomy tech
Penumbra has posted positive data for its computer-assisted vacuum thrombectomy (CAVT) technology aimed at treating patients with intermediate-risk pulmonary embolism …
Penumbra has posted positive data for its computer-assisted vacuum thrombectomy (CAVT) technology aimed at treating patients with intermediate-risk pulmonary embolism …
Zymeworks has dosed the first patient in its Phase I clinical trial of ZW191, an investigational therapy, aimed at treating …
Having raised the full-year sales guidance for Caplyta (lumateperone) a week ago, Intra-Cellular Therapeutics has reported positive topline data from …
Donald Trump has been elected 47th president of the US after the 5 November election having won more than the …
Ankyra Therapeutics has announced the dosing of the first patient with a visceral tumour in part two of its Phase …
Research Grid has raised a $6.5m seed funding round led by Fuel Ventures, aimed at advancing its mission to expedite …
Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral …
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of …
In the Canadian province of Nunavut, geographic remoteness, harsh climate and historic disadvantages have exacerbated public health inequities for its …
The US Food and Drug Administration (FDA) has approved an investigational new drug (IND) application from Damona Pharmaceuticals, allowing it …
Shares in Viking Therapeutics jumped after the company shared positive data from an early-stage trial of its obesity pill but …
Johnson & Johnson’s (J&J) Shockwave Medical unit has reported that its Javelin peripheral intravascular lithotripsy (IVL) catheter system successfully met …
Allurion Technologies has presented data from two studies showing the efficacy of its swallowable gastric balloon in causing significant weight …
Biopharmaceutical company Angitia Biopharmaceuticals has begun a Phase II clinical trial of AGA2118, a bispecific antibody designed for treating osteoporosis. The …
The world of clinical trials is undergoing a rapid change. Today, the rise of decentralized clinical trials (DCTs) and hybrid …